Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 62

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 62
---
 market price, including changes in price caused by factors unrelated to Clearwater’s performance or prospects. Specific factors that may have a significant effect on the market price of Clearwater Common Stock include:

| • |     | changes in stock market analyst recommendations or earnings estimates regarding Clearwater Common Stock or other 
 comparable companies;                                                                                            |

| • |     | actual or anticipated fluctuations in Clearwater’s revenue stream or future prospects; |

| • |     | reaction to public announcements by Clearwater before or after the Transactions; |

| • |     | strategic actions taken by Clearwater or its competitors, such as acquisitions; |

| • |     | potential future public offerings of Clearwater Common Stock, which may dilute stockholders; |

| • |     | the failure of Clearwater to achieve the perceived benefits of the Transactions, including expected financial                  
 results and anticipated synergies, as rapidly as or to the extent anticipated by Clearwater or financial or industry analysts; |

| • |     | new laws or regulations or new interpretations of existing laws or regulations applicable to Clearwater’s 
 business and operations;                                                                                  |

| • |     | changes in tax or accounting standards, policies, guidance, interpretations or principles; and |

| • |     | adverse conditions in the financial markets or general U.S. or international economic conditions, including those 
 resulting from war, incidents of terrorism and responses to such events.                                          |

Also, Clearwater Stockholders and Enfusion Stockholders may not wish to continue to invest in the combined company or may wish to reduce their investment in the combined company, including in order to comply with institutional investing guidelines, to increase diversification, to track any rebalancing of stock indices in which Clearwater Common Stock is included, to respond to the risk profile of the combined company or to realize a gain. If, following completion of the Merger, large amounts of Clearwater Common Stock are sold, the price of Clearwater Common Stock could decline. If the Transactions are completed, Clearwater may not achieve the anticipated benefits of the Transactions, including anticipated synergies. There can be no assurance that Clearwater will be able to successfully integrate Enfusion, and the anticipated benefits of the Transactions, including the anticipated operational and other synergies between the companies, may not be realized fully or at all or may take longer to realize than expected or may have 37

unanticipated adverse results. Anticipated benefits are based on expectations about the future that are subject to change (such as assumptions about Clearwater’s future service costs, future